Shots In The Dark: Why Access To A Covid-19 Vaccine Isn’t Guaranteed
AbbVie Proves Masterful at Playing Drug Patent Game
AbbVie, already famous for its Humira strategy, forms another ‘patent wall’ around Imbruvica: report
The Loopholes Drug Companies Use to Keep Prices High
The Battle for Erlotinib – High Court Decision Raises a Number of Procedural and Practice Issues